Atlas Trials

Gemcitabine and Docetaxel in Treating Patients With Recurrent or Persistent Uterine Cancer

Clinical trial NCT00114218 · COMPLETED

Trial details

NCT number
NCT00114218
Sponsor
Gynecologic Oncology Group
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Recurrent Uterine Corpus SarcomaUterine Carcinosarcoma
Start date
2005-03-01
Primary completion
2010-07-01
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.